1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA VIP CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA CXCR2 CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA RPS6KA1 CTRPv2 pan-cancer AAC 0.16 6e-05
mRNA APOBR CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA SNTB2 CTRPv2 pan-cancer AAC -0.15 6e-05
mRNA NEMP1 CTRPv2 pan-cancer AAC -0.15 7e-05
mRNA PLP1 CTRPv2 pan-cancer AAC 0.18 7e-05
mRNA KNSTRN CTRPv2 pan-cancer AAC -0.14 7e-05
mRNA EML1 CTRPv2 pan-cancer AAC -0.16 7e-05
mRNA MAP4K1 CTRPv2 pan-cancer AAC -0.18 7e-05
Download CSV